Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
City of Hope Medical Center
ClinicalTrials.gov Identifier:
NCT01287871
First received: January 31, 2011
Last updated: October 12, 2012
Last verified: October 2012

January 31, 2011
October 12, 2012
January 2011
October 2012   (final data collection date for primary outcome measure)
Evaluation of the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline [ Time Frame: 3 months after the intervention is implemented ] [ Designated as safety issue: No ]

To evaluate the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer, by determining whether, among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline, degree of exposure to the intervention is associated with the following endpoints at 3 months after the intervention is implemented:

  1. post-intervention change in stigma score relative to pre-intervention, and
  2. Pap testing (scored as 0=made no attempt, 1=made some attempt but did not get tested, 2=obtained Pap test).
Same as current
Complete list of historical versions of study NCT01287871 on ClinicalTrials.gov Archive Site
  • Assessment of whether change in stigma score is associated with Pap testing. [ Time Frame: 3 months after the intervention is implemented ] [ Designated as safety issue: No ]
  • Identification of factors associated with exposure to the intervention overall and to its individual components [ Time Frame: 3 months after the intervention is implemented ] [ Designated as safety issue: No ]
  • Assessment of whether each component of the intervention is associated with the study endpoints, by testing the 4 components (billboards/posters, newspaper advertisements, health brochures, and radio announcements) rather than the overall exposure score [ Time Frame: 3 months after the intervention is implemented ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

This study aims to 1) implement a culturally and contextually rooted innovative multifoci, social marketing intervention involving societal focused media campaign elements to break down the barriers and facilitate timely and appropriate screening practices for cervical cancer; 2) measure cervical cancer stigma from a culturally relevant theoretical and conceptual framework; and 3) assess the influence of stigma on hindering seeking the PAP test. Further, this is an international study that will bring together a multi-disciplinary investigatory team, community advocates and State health agencies to deliver a social marketing intervention in Southern California (the Inland Empire region specifically) and Trinidad and Tobago.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

200 participant recruited from the Inland Empire, Trinidad and Tobago

Cervical Cancer Screening
Not Provided
Social media intervention
Women between the ages of 18-70 who have not been diagnosed with any type of cancer and are of African descent or Latina
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
332
October 2012
October 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

Women will be included if they:

  1. have not been diagnosed with any type of cancer
  2. are between the ages of 18-70
  3. self-identify as being African descended or Latina
  4. are able to speak English and/or Spanish
  5. acknowledge that a Pap test is currently needed

Exclusion Criteria:

  1. Cervical cancer is diagnosed only in women, therefore this study only includes women
  2. Women who have been and/or are currently diagnosed with any type of cancer will be excluded
  3. Women with other major medical conditions (e.g. stroke and degenerative illness) will be excluded
  4. During the screening the level of symptomatology for depression and anxiety will be assessed. Women with severe depression and anxiety will be excluded, but appropriate psychological follow-up and referral will be provided
  5. Women older than 70 years will be excluded
Female
18 Years to 70 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01287871
09136
Yes
City of Hope Medical Center
City of Hope Medical Center
Not Provided
Principal Investigator: Kimlin Ashing-Giwa, PhD City of Hope Medical Center
City of Hope Medical Center
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP